Abstract:Abstract Epidemiological studies have suggested luteolin (3′,4′,5,7-tetrahydroxyflavone) as a potential cancer preventive agent. Recently we found that luteolin selectively kills lung cancer but not immortalized human normal bronchial epithelial cells (HBECs). To elucidate the mechanism of luteolin's cancer cell killing activity, we investigated the cytotoxic cellular signaling pathway in lung cancer cells. The results show that luteolin potently induced both apoptosis and necrosis, which was associated with mitochondrion-dependent superoxide accumulation in lung cancer cells. The c-Jun N-terminal kinase (JNK) was substantially activated in luteolin treated cancer cells and luteolin-induced cytotoxicity was effectively blocked when JNK was inhibited. The reactive oxygen species scavengers BHA and NAC, which effectively block luteolin-induced superoxide accumulation, potently suppressed luteolin-induced JNK activation and cytotoxicity, suggesting that luteolin's lung cancer cell killing requires superoxide-mediated JNK activation. Furthermore, JNK activation was tightly associated with a superoxide-dependent rapid reduction of the JNK inactivating phosphatase MKP-1, which was mainly due to destabilizing MKP-1 protein. These results suggest that inhibiting MKP-1 is the main mechanism for luteolin-induced JNK activation. Thus, luteolin activates a novel cytotoxic pathway consisting of superoxide, MKP-1 and JNK in lung cancer cells. Interestingly, luteolin failed in inducing MKP-1 degradation and JNK activation and cell death in the HBECs, although superoxide induction by luteolin was comparable to that in lung cancer cells. Therefore, luteolin-induced cellular signaling in normal and lung cancer cells diverges at JNK activation. Taken together, our results suggest that activation of the speroxide/MKP1/JNK pathway underlies the main mechanism of luteolin's selective ctyotoxicity in lung cancer cells and manipulation of this pathway could be a useful approach for applying luteolin for lung cancer prevention and therapy. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3797.

Antioxidant and Cytotoxicity Effects of Luteolin

Effect of Luteolin and its combination with chemotherapeutic drugs on cytotoxicity of cancer cells]

Research progress on anti-tumor effects of luteolin]

Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy

Effects of Luteolin on Endothelial Cell Injury Induced by H2O2

Protective effect of luteolin against oxidative stress‐mediated cell injury via enhancing antioxidant systems

Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.

Luteolin Inhibits Nrf2 Leading to Negative Regulation of the Nrf2/Are Pathway and Sensitization of Human Lung Carcinoma A549 Cells to Therapeutic Drugs

Protective effect of luteolin on cigarette smoke extract-induced cellular toxicity and apoptosis in normal human bronchial epithelial cells via the Nrf2 pathway.

Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization.

A Review on the Antioxidative and Prooxidative Properties of Luteolin

Luteolin: a flavonoid with a multifaceted anticancer potential

Abstract 3797: Luteolin Induces Cytotoxicity in Lung Cancer Cells Depending on Superoxide-Mediated MKP-1 Degradation and JNK Activation

Cytotoxicity of luteolin, a flavonoid compound isolated from Anthemis palestina

Luteolin suppresses growth and migration of human lung cancer cells

Abstract A63: Superoxide-dependent MKP-1 Degradation and JNK Activation Contribute to Luteolin-Induced Cytotoxicity in Lung Cancer Cells

The effect of Luteolin on DNA damage mediated by a copper catalyzed Fenton reaction

A Critical Role Of Luteolin-Induced Reactive Oxygen Species In Blockage Of Tumor Necrosis Factor-Activated Nuclear Factor-Kappa B Pathway And Sensitization Of Apoptosis In Lung Cancer Cells

Luteolin Sensitizes Two Oxaliplatin-Resistant Colorectal Cancer Cell Lines to Chemotherapeutic Drugs Via Inhibition of the Nrf2 Pathway

Effects and Mechanisms of Luteolin, a Plant-Based Flavonoid, in the Prevention of Cancers via Modulation of Inflammation and Cell Signaling Molecules

Role of Luteolin Extracted from Clerodendrum Cyrtophyllum Turcz Leaves in Protecting HepG2 Cells from TBHP-induced Oxidative Stress and Its Cytotoxicity, Genotoxicity